Literature DB >> 2999260

Secretory and serum immunoglobulin class-specific antibodies to poliovirus after vaccination.

B Carlsson, S Zaman, L Mellander, F Jalil, L A Hanson.   

Abstract

Immune responses in serum and saliva were studied in Pakistani children by enzyme-linked immunosorbent assay after natural exposure to poliovirus and vaccination with live or inactivated poliovirus vaccines. Swedish children unexposed to wild poliovirus who had almost 100% vaccination coverage with inactivated vaccine at 8, 9, and 18 months and at 5 years of age were analyzed for comparison. Natural exposure induced secretory IgA (SIgA) antibodies to poliovirus in the saliva of Pakistani infants at one month of age that reached adult levels at six months. No difference in levels of salivary antibody at eight months was observed between groups vaccinated with either live or inactivated vaccines. Vaccination with live or inactivated vaccine starting at 2 or 3 months of age resulted in high titers of IgG antibody to poliovirus in serum, the highest of which occurred after four doses of live vaccine. In Sweden, an increase of antibody in serum was observed after the third vaccination. IgA antibodies continued to increase subsequently, whereas IgG antibodies reached a plateau. The SIgA response in saliva initially appeared on the third vaccination, with a significant increase after the fourth. Repeated vaccination with inactivated poliovirus vaccine induces specific SIgA antibodies. Adults all had SIgA antibodies to poliovirus in saliva.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999260     DOI: 10.1093/infdis/152.6.1238

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Intestinal trypsin can significantly modify antigenic properties of polioviruses: implications for the use of inactivated poliovirus vaccine.

Authors:  M Roivainen; T Hovi
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Secretory IgA and IgM antibodies to E. coli O and poliovirus type I antigens occur in amniotic fluid, meconium and saliva from newborns. A neonatal immune response without antigenic exposure: a result of anti-idiotypic induction?

Authors:  L Mellander; B Carlsson; L A Hanson
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

3.  Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands.

Authors:  M M Herremans; A M van Loon; J H Reimerink; H C Rümke; H G van der Avoort; T G Kimman; M P Koopmans
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

4.  Inadequacy of mucosal IgM antibodies in selective IgA deficiency: excretion of attenuated polio viruses is prolonged.

Authors:  E Savilahti; T Klemola; B Carlsson; L Mellander; M Stenvik; T Hovi
Journal:  J Clin Immunol       Date:  1988-03       Impact factor: 8.317

5.  Isotype, subclass and molecular size of immunoglobulins in salivas from young infants.

Authors:  D J Smith; W F King; M A Taubman
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

6.  Diagnosis of norwalk virus infection by indirect enzyme immunoassay detection of salivary antibodies to recombinant norwalk virus antigen.

Authors:  Christine L Moe; Arnie Sair; Lisa Lindesmith; Mary K Estes; Lee-Ann Jaykus
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

7.  Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.

Authors:  L Fiore; B Ridolfi; D Genovese; G Buttinelli; S Lucioli; A Lahm; F M Ruggeri
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.

Authors:  D Cohen; N Orr; G Robin; R Slepon; S Ashkenazi; I Ashkenazi; J Shemer
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

9.  Poliovirus antibody titres, relative affinity, and neutralising capacity in maternal milk.

Authors:  S Zaman; B Carlsson; A Morikawa; S Jeansson; I Narayanan; K Thiringer; F Jalil; L A Hanson
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

10.  Secretory antibodies in IgA-deficient and immunosuppressed individuals.

Authors:  L Mellander; J Björkander; B Carlsson; L A Hanson
Journal:  J Clin Immunol       Date:  1986-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.